Spermosens Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Tore Duvold
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
CEO
Tore Duvold (56 yo)
less than a year
Tenure
Mr. Tore Duvold serves as Chief Executive Officer at Spermosens AB from May 01, 2024. He served as Chief Executive Officer at Coegin Pharma AS since September 2020 until 2023 and served as its Director sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 3.4yrs | kr1.01m | 0.088% SEK 1.3k | |
| Chief Executive Officer | less than a year | no data | no data | |
| Chief Technology Officer | 1.3yrs | no data | no data | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Principal Scientist | 2.3yrs | no data | no data |
1.3yrs
Average Tenure
Experienced Management: 9R5's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 4.4yrs | kr247.00k | 0.036% SEK 527.6 | |
| Independent Director | 4.4yrs | kr68.00k | 0.14% SEK 2.0k | |
| Director | 6.4yrs | kr76.00k | 0.58% SEK 8.5k | |
| Independent Director | 5.4yrs | kr139.00k | no data | |
| Member of Advisory Board | 2.9yrs | no data | no data | |
| Member of Advisory Board | 2.9yrs | no data | no data | |
| Member of Advisory Board | 2.9yrs | no data | no data | |
| Member of Advisory Board | 2.9yrs | no data | no data | |
| Independent Director | 2.1yrs | kr76.00k | no data |
2.9yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 9R5's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.